TTNP TITAN PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Management Changes Titan Pharmaceuticals appointed Enrome LLP as its new independent auditor for 2024 and appointed Chay Weei Jye as CEO effective December 2, 2024.Get access to all SEC 8-K filings of the TITAN PHARMACEUTICALS INC